| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/09/2008 | CN100379417C Application of sophocarpine in use of making medicines |
| 04/09/2008 | CN100379416C Stable solid medicinal composition for oral administration. |
| 04/09/2008 | CN100379415C Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 04/09/2008 | CN100379414C Use of an opuntia ficus-indica extract and compounds isolated therefrom for protecting nerve cells |
| 04/09/2008 | CN100379413C Preparation for improving the action of receptors |
| 04/09/2008 | CN100379412C Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of hyperuricemia |
| 04/09/2008 | CN100379411C Use of compound for treating tinnitus |
| 04/09/2008 | CN100379410C Therapeutic drug for diabetes |
| 04/09/2008 | CN100379406C Method for preparing tiny pellets of difficult soluble drugs and formulation containing the pellets |
| 04/09/2008 | CN100379405C Method of preparing dry powder inhalation compositions |
| 04/09/2008 | CN100379404C Liposome composition for reduction of liposome-induced complement activation |
| 04/09/2008 | CN100379395C Method for covering an open wound, and manufacturing of a wound dressing for covering an open wound |
| 04/09/2008 | CN100379341C Synergistic microbicidal combination |
| 04/09/2008 | CN100379340C Highly crosslinked biocidal polystyrene hydantoin particles |
| 04/08/2008 | US7355081 androgen receptor antagonists; certain cancers, baldness, hirsutism, behavioral disorders, acne, and inhibition of spermatogenesis if so desired |
| 04/08/2008 | US7355079 Thyronamine derivatives and analogs and methods of use thereof |
| 04/08/2008 | US7355074 Especially calix[4]arene amides, e.g., calix[4]arene tetrabutylamide-1,3-alt; capable of forming a chloride ion channel across a lipid bilayer, and transporting chloride ion across the bilayer |
| 04/08/2008 | US7355069 2-[2-(4-{2-[ethyl(2-fluorobenzyl)amino]-2-oxoethoxy}phenyl)ethoxy]benzoic acid; peroxisome proliferator-activated receptors alfa agonist; antidiabetic, hypotensive agent; obesity, elevated VLDL (Very Low Density Lipoproteins) and reduced HDL (High Density Lipoprotein) concentrations |
| 04/08/2008 | US7355056 Transferring agent into cells; using polypeptides, polynucleotides, antibodies nucleic acids ; tumor suppressor gene; anticancer agents |
| 04/08/2008 | US7355054 Indole derivatives |
| 04/08/2008 | US7355053 1-phenylpyrrolidine-2-one-3-carboxamides |
| 04/08/2008 | US7355051 Piperdine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication |
| 04/08/2008 | US7355047 Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof |
| 04/08/2008 | US7355046 Chronic obstructive pulmonary dusease; asthma |
| 04/08/2008 | US7355042 Sleep disorders; side effect reduction |
| 04/08/2008 | US7355035 Catalytic molecules |
| 04/08/2008 | US7355024 Regulatory sequences for modulation of INGAP expression and reporter constructs |
| 04/08/2008 | US7355023 Isolated nucleic acids and polypeptides associated with glucose homeostasis disorders and method of detecting the same |
| 04/08/2008 | US7355001 Diagnostic marker for diseases associated with the liver, pancreas , immunological system (thymus failure), reproduction, digestive system, skin, central nervous system, spleen, respiratory system, and thyroid hormone, and diabetes, hypertension, cancer, reperfusion injury following ischemia, retinitis |
| 04/08/2008 | US7354966 Compounds for use as surfactants |
| 04/08/2008 | US7354955 (2S)-amino(phenyl)acetic acid and derivatives as α2δ voltage-gated calcium channel ligands |
| 04/08/2008 | US7354954 Use of GABA agonists for treatment of spastic disorders, convulsions, and epilepsy |
| 04/08/2008 | US7354953 Administering Cr3O(carboxylate)6(ligand)3]+ (3)wherein carboxylate is a C2-C5 alkyl carboxylate and wherein the ligand is a ligand that (i) renders the chromium complex insoluble or only slightly soluble in water and (ii) is acid labile; diabetes |
| 04/08/2008 | US7354952 Pharmaceutical gallium compositions and methods |
| 04/08/2008 | US7354951 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 04/08/2008 | US7354950 1,3-Dioxane derivatives, composition, optical element and display device containing the same |
| 04/08/2008 | US7354949 Therapeutic agent for bladder irritative symptoms associated with benign prostatic hyperplasia |
| 04/08/2008 | US7354948 Methods for treatment of chronic uveitis using cyclopropyl-n-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide |
| 04/08/2008 | US7354947 Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof a JNK inhibitors and compositions and methods related thereto |
| 04/08/2008 | US7354946 Biarylurea derivatives |
| 04/08/2008 | US7354945 Compounds as enzyme inhibitors, cosmetics, antitumor agents and food supplements |
| 04/08/2008 | US7354944 protein kinase B inhibitors; abnormal cell growth, cancer, inflammation, and metabolic disordersp; 3-(3-Fluoro-phenyl)-N-[5-(3-methyl-1H-indazol-5-yl)-[1,3,4]thiadiazol-2-yl]-propane-1,2-diamine |
| 04/08/2008 | US7354943 Statine derivatives for the treatment of Alzheimer's disease |
| 04/08/2008 | US7354942 Benzylether and benzylamino beta-secretase inhibitors for the treatment of Alzheimer's disease |
| 04/08/2008 | US7354941 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes |
| 04/08/2008 | US7354940 2,5-dioxoimidazolidin-4-yl acetamines and analogues as inhibitors of metalloproteinase mmp12 |
| 04/08/2008 | US7354939 Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto |
| 04/08/2008 | US7354938 4[2(2,4chlorophenyl)pyrazol]-phenyl-cyclopropan; 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor; antidiabrtic agent, obesity, insulin resistance; improved physicochemical (stability) and biological (activity to inhibit HSD1, specificity, bioavailability, metabolism) |
| 04/08/2008 | US7354937 (1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane |
| 04/08/2008 | US7354936 2-phenylpyran-4-one derivatives |
| 04/08/2008 | US7354935 [18F][2-fluorodideuteromethoxy-5-(5-trifluoromethyl-tetrazol-1-yl)-benzyl]-([2S,3S]-2-phenyl-piperidin-3-yl)-amine; image of neurokinin-1 receptors using positron emission tomography; detection or quantification; bioassay; brain, tissues, inflammation where substance P is involved, Alzheimer's disease |
| 04/08/2008 | US7354934 N1-(1H-Benzimidazol-2-ylmethyl)-N1-(5,6,7,8-tetrahydro-quinolin-8-yl)-butane-1,4-diamine; fusin and chemokine receptor antagonist; increase progenitor and stem cells in humans; HIV, antiinflammatory agent: rheumatoid arthritis, inflammatory bowel disease |
| 04/08/2008 | US7354933 Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 04/08/2008 | US7354932 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 04/08/2008 | US7354931 Treating obstructive airway disorders using nontoxic drug |
| 04/08/2008 | US7354930 N-biarylamides |
| 04/08/2008 | US7354929 6-benzyl-3-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-2,6-dihydropyrazolo[3,4-c]pyridin-7-one; eating and psychological disorders; obesity, alcoholism |
| 04/08/2008 | US7354928 Therapeutic treatment with an antiapoptotic agents, antitumor agents, anticarcinogenic agents |
| 04/08/2008 | US7354927 6H-[1]benzopyrano[4,3-b]quinolines and their use as estrogenic agents |
| 04/08/2008 | US7354926 Molecules derived from noraporphine |
| 04/08/2008 | US7354925 Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as ORL1-receptor antagonists |
| 04/08/2008 | US7354924 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| 04/08/2008 | US7354923 Piperazine melanocortin-specific compounds |
| 04/08/2008 | US7354921 Pyrazolotriazines as kinase inhibitors |
| 04/08/2008 | US7354920 Aryl and heteroaryl morpholine derivatives |
| 04/08/2008 | US7354919 Isoxazole compositions useful as inhibitors of ERK |
| 04/08/2008 | US7354918 cerebral oxygenators and vasoregulators; antidepressant, cognition activator; sleep disorders; enantiomer mixture separated by HPLC; classical antidepressants resistance |
| 04/08/2008 | US7354917 Oxabispidine compounds and their use in the treatment of cardiac arrhythmias |
| 04/08/2008 | US7354916 Tumor suppression agents with reduced side effects; anticancer; antibacterial and antiviral |
| 04/08/2008 | US7354915 as agonist; treatment of uterine fibroids, endometriosis, dysmenorrhea; anticarcinogenic: breast, uterine, ovarian, prostate cancers and meningioma; hormone replacement therapy; menopausal and post-menopausal hormone replacement therapy; skin disorders |
| 04/08/2008 | US7354914 1-[3-Methyl-1-(5-methyl-6-oxo-benzo[b]-1,4-oxazepin-7-ylcarbamoyl)-butyl]-cyclohexanecarboxylic acid amide; inhibit processing of amyloid precursor protein (production of A beta -peptide); neurological disorders related to beta -amyloid production: Alzheimer's disease, Down's Syndrome |
| 04/08/2008 | US7354913 High storage stability inhalable compositions |
| 04/08/2008 | US7354912 For therapy of osteoporosis |
| 04/08/2008 | US7354910 Agent for treating inflammatory bowel diseases |
| 04/08/2008 | US7354909 Incubating dendritic precursor cells such as monocytes and plasmacytoid dendritic cells with immunostimulatory oligonucleotide to generate antigen presenting cells for use in treatment of cell proliferative disorders; immunotherapy |
| 04/08/2008 | US7354907 immunomer comprising two or more oligonucleotide branches linked together; can cause immune stimulation across species lines; less expensive to make |
| 04/08/2008 | US7354906 Composition of anti-HIV drugs and anti-cortisol compounds and method for decreasing the side effects of anti-HIV drugs in a human |
| 04/08/2008 | US7354905 Thrombosis therapy; anticoagulants |
| 04/08/2008 | US7354898 Identifying agents which modify mitogen activated kinase activities associated with cell death; small interfering RNA and treament of cell proliferative disorders; for modulating diseases and conditions associated with elevated or decreased apoptosis |
| 04/08/2008 | US7354895 Phosphinyloxy, oxime and carboxylic acid derivatives which are useful as carboxypeptidase U inhibitors |
| 04/08/2008 | US7354894 Administering epidermal growth factor receptor antagonist; blocking with monoclonal antibody, a kinase inhibitor, a metalloproteinase inhibitor; treating nasal polyps, chronic obstructive pulmonary disease |
| 04/08/2008 | US7354765 Soybean plants with enhanced expression of daidzein and genistein; for use in improving nutrient quality of foods |
| 04/08/2008 | US7354737 peptide delivers biological response modifiers into cytoplasm, intracellular organelles or nucleus of prokaryotic/eukaryotic cells; use in drug delivery, vaccines, gene and protein therapy |
| 04/08/2008 | US7354736 Intracellular caspase inhibitory polypeptide for use in treatment and prevention of cell proliferative, nervous system and autoimmune disorders |
| 04/08/2008 | US7354724 Drosophila G protein coupled receptors, nucleic acids, and methods related to the same |
| 04/08/2008 | US7354711 Comprises 9-aminoacridines and 4-aminoquinolines; for treatment of lupus; interleukins; immunoglobulins; drug screening |
| 04/08/2008 | US7354610 Phospholipid complexes of standardized vegetable extract of Vitis vinifera and of standardized vegetable extract of Centella asiatica; may also include vitamin E, zinc, hydroxyacids, or glycyrrhetinic acid or its complex with phospholipids; does not contain fish cartilage extract |
| 04/08/2008 | US7354606 touchi plant extract and phaseolamin mixture for limiting the absorption of carbohydrates contained in a foodstuff, for promoting weight loss in an individual; nutraceuticals |
| 04/08/2008 | US7354604 2-Furancarboxylic acid, benzoic acid and salicylic acid and benzyl alcohol; effective against mycobacteria and bacterial endospores; alkyl diphenyl sulfonate surfactant, nonionic or anionic surfactants, corrosion inhibitors, cation sequestering agents, or buffer |
| 04/08/2008 | US7354601 Particulate materials |
| 04/08/2008 | US7354590 Methods of producing edible fungi containing activated folates and nutritional supplements containing activated folates |
| 04/08/2008 | US7354579 Method of treating cancer with a VEGF antagonist and an anti-proliferative agent |
| 04/08/2008 | US7354574 Treatment of ocular disease |
| 04/08/2008 | CA2384739C Plastic films, especially for use in a dermal or transdermal therapeutic system |
| 04/08/2008 | CA2372962C Novel interleukin-1 and tumor necrosis factor-.alpha. modulators, syntheses of said modulators and methods of using said modulators |
| 04/08/2008 | CA2349620C Use of aliphatic polyamines for reducing oxalate |
| 04/08/2008 | CA2337886C Pharmaceutical compositions comprising hydroxylansoprazole and uses thereof |
| 04/08/2008 | CA2305764C Bile acid salts of metals with physiological action and the use thereof in therapy |
| 04/08/2008 | CA2295588C Nanocrystalline formulations of human immunodeficiency virus (hiv) protease inhibitors using cellulosic surface stabilizers and methods of making such formulations |
| 04/08/2008 | CA2273298C Product and method for the treatment of hyperlipidemia |